Thomas Pagliardini

683 total citations
16 papers, 240 citations indexed

About

Thomas Pagliardini is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Thomas Pagliardini has authored 16 papers receiving a total of 240 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 7 papers in Oncology and 6 papers in Immunology. Recurrent topics in Thomas Pagliardini's work include Hematopoietic Stem Cell Transplantation (12 papers), Immune Cell Function and Interaction (5 papers) and Acute Myeloid Leukemia Research (4 papers). Thomas Pagliardini is often cited by papers focused on Hematopoietic Stem Cell Transplantation (12 papers), Immune Cell Function and Interaction (5 papers) and Acute Myeloid Leukemia Research (4 papers). Thomas Pagliardini collaborates with scholars based in France, Italy and Lebanon. Thomas Pagliardini's co-authors include Didier Blaise, Raynier Devillier, Luca Castagna, Samia Harbi, Christian Chabannon, Angéla Granata, Norbert Vey, Anne-Sophie Chrétien, Claude Lemarié and Daniel Olive and has published in prestigious journals such as Blood, Cancer and Journal of Leukocyte Biology.

In The Last Decade

Thomas Pagliardini

16 papers receiving 234 citations

Peers

Thomas Pagliardini
Comparison fields: 5 of 30
  • Hematology 195
  • Oncology 101
  • Genetics 79
  • Immunology 75
  • Rheumatology 43
Replace H-J Kolb with:
H-J Kolb Germany
Heike Schieder Germany
K Miyamura Japan
James H. Jerkins United States
Olga Mulas Italy
Valério Maisano France
Anna Lübking Sweden
Yasuji Kouzai Japan
Catrin Theuser Germany
Carme Talarn Spain
H-J Kolb Germany View profile →
Citations per field, relative to Thomas Pagliardini
Thomas Pagliardini · 1×
Citations per year, relative to Thomas Pagliardini
Thomas Pagliardini · 1×

Countries citing papers authored by Thomas Pagliardini

Since Specialization
Citations

This map shows the geographic impact of Thomas Pagliardini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Pagliardini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Pagliardini more than expected).

Fields of papers citing papers by Thomas Pagliardini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Pagliardini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Pagliardini. The network helps show where Thomas Pagliardini may publish in the future.

Co-authorship network of co-authors of Thomas Pagliardini

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Pagliardini. A scholar is included among the top collaborators of Thomas Pagliardini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Pagliardini. Thomas Pagliardini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
# Work Indexed citations
1
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease
2024 ·Bone Marrow Transplantation ·Sabine Fürst, E. Bernit, Faézeh Legrand, Angéla Granata, Samia Harbi, Raynier Devillier, Valério Maisano, (unknown), Thomas Pagliardini, Djamel Mokart, Claude Lemarié, Boris Calmels, Christophe Picard, Agnès Basire, Börje S. Andersson, Didier Blaise
2
2
GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation
2023 ·Bone Marrow Transplantation ·(unknown), Sabine Fürst, Boris Calmels, Thomas Pagliardini, Samia Harbi, (unknown), (unknown), Claude Lemarié, (unknown), (unknown), Faézeh Legrand, (unknown), Angéla Granata, Pierre Jean Weiller, Christian Chabannon, Jean‐Marc Schiano de Colella, Norbert Vey, Didier Blaise, Raynier Devillier
2
3
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome
2023 ·Bone Marrow Transplantation ·Samia Harbi, (unknown), (unknown), Sylvain Garciaz, Thomas Pagliardini, Boris Calmels, (unknown), (unknown), Yosr Hicheri, Sabine Fürst, Claude Lemarié, (unknown), Faézeh Legrand, (unknown), Pierre Jean Weiller, Christian Chabannon, Norbert Vey, Didier Blaise, Raynier Devillier
8
4
Higher Grade Cytokine Release Syndrome Is a Predictive Factor for Gvhd in Haploidentical Stem Cell Transplantation with Peripheral Blood Cell
2021 ·Blood ·(unknown), Valério Maisano, (unknown), Angéla Granata, Sabine Fürst, Faézeh Legrand, Thomas Pagliardini, (unknown), Samia Harbi, Pierre‐Jean Weiller, Julien Mozziconacci, Claude Lemarié, Boris Calmels, Christian Chabannon, Didier Blaise, Raynier Devillier
1
5
Safety of Anti-NKG2A Blocking Antibody Monalizumab As Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Study
2021 ·Blood ·Raynier Devillier, Sabine Fürst, (unknown), Thomas Pagliardini, (unknown), Valério Maisano, Angéla Granata, Faézeh Legrand, Jihane Pakradouni, Jean‐Marie Boher, Cyril Fauriat, Anne-Sophie Chrétien, Christian Chabannon, Norbert Vey, Éric Vivier, Daniel Olive, Didier Blaise
7
6
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome
2020 ·Bone Marrow Transplantation ·Luca Castagna, Thomas Pagliardini, Stéfania Bramanti, Jean‐Marc Schiano de Colella, (unknown), Réda Bouabdallah, Jacopo Mariotti, Sabine Fürst, Angéla Granata, Chiara De Philippis, Samia Harbi, Barbara Sarina, Faézeh Legrand, Valério Maisano, Pierre Jean Weiller, Christian Chabannon, Carmelo Carlo‐Stella, Armando Santoro, Didier Blaise, Raynier Devillier
6
7
Impact of Adding Antithymocyte Globulin to Posttransplantation Cyclophosphamide in Haploidentical Stem-Cell Transplantation
2020 ·Clinical Lymphoma Myeloma & Leukemia ·Jean El Cheikh, Raynier Devillier, Rémy Duléry, Radwan Massoud, (unknown), (unknown), Nour Moukalled, Thomas Pagliardini, (unknown), Florent Malard, Abdul Hamid Bazarbachi, Razan Mohty, Ali Bazarbachi, Luca Castagna, Mohamad Mohty, Didier Blaise
23
8
Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin Lymphomas
2020 ·Biology of Blood and Marrow Transplantation ·(unknown), Luca Castagna, Chiara De Philippis, Stéfania Bramanti, Jean‐Marc Schiano de Colella, Thomas Pagliardini, (unknown), Samia Harbi, Jacopo Mariotti, Angéla Granata, Valério Maisano, Sabine Fürst, (unknown), Christian Chabannon, Carmelo Carlo‐Stella, Armando Santoro, Didier Blaise, Raynier Devillier
4
9
Mechanisms of NK cell dysfunction in the tumor microenvironment and current clinical approaches to harness NK cell potential for immunotherapy
2020 ·Journal of Leukocyte Biology ·Raynier Devillier, Anne-Sophie Chrétien, Thomas Pagliardini, (unknown), Didier Blaise, Daniel Olive
29
10
Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation
2019 ·Bone Marrow Transplantation ·(unknown), Angéla Granata, Thomas Pagliardini, Luca Castagna, Samia Harbi, Réda Bouabdallah, Norbert Vey, Sabine Fürst, Valério Maisano, Faézeh Legrand, Claude Lemarié, Boris Calmels, Christian Chabannon, Pierre‐Jean Weiller, Didier Blaise, Raynier Devillier
18
11
Peripheral Blood Stem Cells versus Bone Marrow for T Cell–Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma
2019 ·Biology of Blood and Marrow Transplantation ·Jacopo Mariotti, Raynier Devillier, Stéfania Bramanti, Laura Giordano, Barbara Sarina, Sabine Fürst, Angéla Granata, Valério Maisano, Thomas Pagliardini, Chiara De Philippis, (unknown), Catherine Faucher, Samia Harbi, Christian Chabannon, Carmelo Carlo‐Stella, Réda Bouabdallah, Armando Santoro, Didier Blaise, Luca Castagna
13
12
Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients
2018 ·Bone Marrow Transplantation ·Thomas Pagliardini, Samia Harbi, Sabine Fürst, Luca Castagna, Faézeh Legrand, Catherine Faucher, Angéla Granata, Pierre‐Jean Weiller, Boris Calmels, Claude Lemarié, Christian Chabannon, Réda Bouabdallah, Djamel Mokart, Norbert Vey, Didier Blaise, Raynier Devillier
19
13
HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison
2018 ·Biology of Blood and Marrow Transplantation ·Raynier Devillier, Faézeh Legrand, Jérôme Rey, Luca Castagna, Sabine Fürst, Angéla Granata, Aude Charbonnier, Samia Harbi, Evelyne D’Incan, Thomas Pagliardini, Catherine Faucher, Claude Lemarié, Colombe Saillard, Boris Calmels, Bilal Mohty, Valério Maisano, Pierre‐Jean Weiller, Christian Chabannon, Norbert Vey, Didier Blaise
30
14
Haploidentical Hematopoietic Stem Cell Allogeneic Transplantation with High Dose Post Transplantation Cyclophosphamide for Patients over 60 Years of Age
2017 ·Blood ·Samia Harbi, Raynier Devillier, Stéfania Bramanti, Thomas Pagliardini, Faézeh Legrand, (unknown), Valério Maisano, (unknown), Angéla Granata, Frédérique Rousseau, Sabine Fürst, Catherine Faucher, Christian Chabannon, Pierre Jean Weiller, Luca Castagna, Didier Blaise
1
15
Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia
2017 ·Cancer ·Laurence Legros, Franck E. Nicolini, Gabriel Étienne, Philippe Rousselot, Delphine Réa, Stéphane Giraudier, Agnès Guerci‐Bresler, Françoise Huguet, Martine Gardembas, Martine Escoffre, Jean‐Christophe Ianotto, Marie‐Pierre Noël, Bruno Varet, Thomas Pagliardini, Isabelle Touitou, Stéphane Morisset, François‐Xavier Mahon, (unknown)
73
16
Second TKI Discontinuation in CML Patients That Failed First Discontinuation and Subsequently Regained Deep Molecular Response after TKI Re-Challenge
2016 ·Blood ·Thomas Pagliardini, Franck E. Nicolini, Stéphane Giraudier, Philippe Rousselot, Gabriel Étienne, Françoise Huguet, Agnès Guerci‐Bresler, Bruno Varet, Martine Escoffre, Stéphane Morisset, François‐Xavier Mahon, Laurence Legros
4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H-J Kolb Breakdown of academic impact, for papers by Heike Schieder Breakdown of academic impact, for papers by K Miyamura Breakdown of academic impact, for papers by James H. Jerkins Breakdown of academic impact, for papers by Olga Mulas Breakdown of academic impact, for papers by Valério Maisano Breakdown of academic impact, for papers by Anna Lübking Breakdown of academic impact, for papers by Yasuji Kouzai Breakdown of academic impact, for papers by Catrin Theuser Breakdown of academic impact, for papers by Carme Talarn
Rankless by CCL
2026